Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Letter Commentary & Co-Mentions | Period / Date | Action |
|---|---|---|---|
“Haleon is a top-ten portfolio holding representing nearly six percent of assets, contributing to the fund's defensive, high-quality, non-cyclical stance.” | Q4 2023 Feb 21, 2024 | Preview | |
“We also exited our position in global consumer health care products company Haleon, which was spun out of GSK in 2022 and had reached our estimate of intrinsic value.” | Q2 2023 Jun 30, 2023 | Preview |
Read unredacted commentary excerpts, portfolio weight disclosures, and high-conviction theses from hedge fund managers discussing $HLN.(1 additional institutional mentions locked).
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
